A detailed history of State Street Corp transactions in Personalis, Inc. stock. As of the latest transaction made, State Street Corp holds 175,142 shares of PSNL stock, worth $753,110. This represents 0.0% of its overall portfolio holdings.

Number of Shares
175,142
Previous 130,242 34.47%
Holding current value
$753,110
Previous $152,000 519.74%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.19 - $6.34 $53,431 - $284,666
44,900 Added 34.47%
175,142 $942,000
Q1 2023

May 15, 2023

BUY
$2.01 - $4.17 $24,320 - $50,457
12,100 Added 10.24%
130,242 $359,000
Q3 2022

Nov 15, 2022

SELL
$2.89 - $5.32 $7,259 - $13,363
-2,512 Reduced 2.08%
118,142 $351,000
Q2 2022

Aug 15, 2022

SELL
$3.27 - $8.76 $1.99 Million - $5.33 Million
-608,422 Reduced 83.45%
120,654 $416,000
Q1 2022

May 16, 2022

BUY
$7.56 - $14.3 $242,237 - $458,200
32,042 Added 4.6%
729,076 $5.97 Million
Q4 2021

Feb 14, 2022

BUY
$12.24 - $21.25 $636,737 - $1.11 Million
52,021 Added 8.07%
697,034 $9.95 Million
Q3 2021

Nov 15, 2021

BUY
$16.69 - $26.05 $636,539 - $993,520
38,139 Added 6.28%
645,013 $12.4 Million
Q2 2021

Aug 16, 2021

BUY
$18.15 - $27.75 $2.53 Million - $3.87 Million
139,526 Added 29.85%
606,874 $15.4 Million
Q1 2021

May 17, 2021

BUY
$20.71 - $51.02 $671,935 - $1.66 Million
32,445 Added 7.46%
467,348 $11.5 Million
Q4 2020

Feb 16, 2021

BUY
$21.84 - $44.0 $1.6 Million - $3.23 Million
73,346 Added 20.29%
434,903 $15.9 Million
Q3 2020

Nov 10, 2020

BUY
$13.63 - $24.12 $196,967 - $348,558
14,451 Added 4.16%
361,557 $7.84 Million
Q2 2020

Aug 14, 2020

BUY
$7.65 - $14.11 $685,677 - $1.26 Million
89,631 Added 34.81%
347,106 $4.5 Million
Q1 2020

May 11, 2020

BUY
$4.75 - $12.41 $1.22 Million - $3.2 Million
257,475 New
257,475 $2.08 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $197M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.